Shashank K R on The Use of Lumbrokinase from Eudrilus eugeniae
Shashank K R, Assistant Lecturer at Yuvaraja’s College, shared on LinkedIn:
”Cardiovascular diseases driven by thrombosis remain a major global health challenge.
Our study focuses on the isolation, purification, and biochemical characterization of lumbrikinase from Eudrilus eugeniae, demonstrating strong fibrinolytic activity, favorable kinetics, and stability under physiological conditions—highlighting its potential as a safer and effective thrombolytic agent for cardiovascular therapeutics.”
Read the full article here.
Article: Exploring the Fibrinolytic and Biochemical characteristics of Lumbrokinase enzyme from Eudrilus eugeniae for Therapeutic Use
Authors: Shashank K R, Malliah Mahadevaswamy
Stay updated on all scientific advances with Hemostasis Today.
-
Oct 5, 2026, 22:55Steve Humphreys: A Big Thank You to BSHT for Providing Me With a Recent Skills Exchange Award
-
Oct 5, 2026, 22:52William McKeown: Great to Be in Istanbul for the Opening of the EHC 2026
-
Oct 5, 2026, 22:48Laura Quintas Lorenzo: A New Approach to Healthcare for von Willebrand Disease at EHC 2026
-
Oct 5, 2026, 22:46Anas Zayad: Pleased to Share Our New Review on Thrombosis in SCD and Beta Thalassemia
-
Oct 5, 2026, 22:44Cihan Ay: Honouring Eric Kandel and Eugene Braunwald at the Medical University of Vienna
-
Oct 5, 2026, 22:42Heather L. Gornik: Testing for Aortic and Arterial Thrombosis at VSS 2026
-
Oct 5, 2026, 22:34Hasan Abbas Zaheer: Honoured to Have Co-Authored One of the Four Reviews in The Lancet Thalassemia Series
-
Oct 5, 2026, 22:34Kamyar Shameli: Understanding the Coagulation Cascade – How Anticoagulants Prevent Blood Clots
-
Oct 5, 2026, 22:31Risika Samanta: Pediatric ITP in a 12-year-old – An Atypical Presentation without a Viral Prodrome